Skip to main content
. 2023 Feb;64(2):294–303. doi: 10.2967/jnumed.122.264031

TABLE 3.

List of 18F-Amyloid Radiopharmaceuticals and Their Recommended Doses, Uptake Times, and Acquisition Durations

Parameter Florbetapir* Flutemetamol Florbetaben NAV4694 (80)
Administered activity (MBq) 370 (maximum, 50-μg mass dose) 185 (maximum, 20-μg mass dose) 300 (maximum, 30-μg mass dose) 300
Uptake time (postinjection min) 30–50 90 45–130 50–70
Acquisition duration (min) 10 20 15–20 20
*

Amyvid (Eli Lilly & Co.) (77).

Vizamyl (GE Healthcare) (78).

Neuraceq (Piramal Imaging) (79).

Data are per U.S. package inserts. There might be some slight variations in package insert information depending on country of approval.